Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof

Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof

US Patent 8772301 · Granted Jul 8, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and compositions and uses thereof2024
Heteroaryl-isochroman compounds and uses thereof2022
1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders2021
Dual NAV1.2/5HT2a inhibitors for treating CNS disorders2021
Dual NAV1.2/5HT2a inhibitors for treating CNS disorders2021
Inhibitors of protease-activated receptor-22021
Compounds and compositions and uses thereof2021
Compounds and uses thereof2020
Metabotrophic glutamate receptor 5 modulators and methods use thereof2020
Metabotrophic glutamate receptor 5 modulators and methods use thereof2020
Metabotrophic glutamate receptor 5 modulators and methods use thereof2020
Metabotrophic glutamate receptor 5 modulators and methods use thereof2020